biotechnology industry valuation

Biotechnology market valuation trends in 2026 reflect a complex environment shaped by capital discipline, regulatory scrutiny, and renewed interest in platform-driven innovation. After a volatile period for biotech equities earlier in the decade, investors and industry strategists are increasingly focused on companies that combine scientific differentiation with clear commercialization pathways. Valuation dynamics are no longer … Read more